oral semaglutide novo Nordisk launched an version of its GLP-1 injectable to US markets on Jan 5. Link in comments Novo Nordisk, aiming for approval

Mounjaro has been shown to produce an average 15.7% reduction in body weight, with almost a third of participants experiencing a reduction exceeding 20%

TribbleJROtmaniASunSEllisSACimagliaGVohraRet al

Here, we provide the first evidence of improved healthspan and age-related survival with a therapeutic mAb by demonstrating that treatment with an IGF-1R antagonist in older mice significantly and preferentially improves several indices of healthspan, reduced death from neoplastic disease, and increased mean and median lifespan in females

This early success is incredibly encouraging and helps many feel motivated to continue and reach their goals

Muscle and Recovery Support Bundle